Search Results (2,070)

α-Synuclein (α-Syn) is a key presynaptic protein, primarily known for its role in the pathogenesis of Parkinson’s disease (PD) and other synucleinopathies, including dementia with Lewy bodies (DLB). Although much of the research has focused on the nigrostriatal dopamine (DA) pathway, there is growing recognition that the accumulation of misfolded α-Syn in the prefrontal cortex (PFC) is a critical driver of non-motor symptoms and cognitive deficits in PD and DLB. This review examines the dual role of α-Syn in the PFC circuitry, initially exploring its regulation of synaptic vesicle (SV) dynamics and recycling to maintain stable neurotransmission. We highlight its contribution to the modulation of glutamatergic (Glu) and GABAergic (γ-aminobutyric acid, GABA) synapses, which ensures the functional excitatory/inhibitory (E/I) balance of prefrontal circuits. Conversely, in PD and DLB, the transition of functional α-Syn monomers to pathological oligomers triggers a cascade of synaptic failures. We analyze how α-Syn aggregation causes pathology in dendritic spines, leads to a progressive reduction in the density of synaptic markers, and impairs cortical plasticity. Synthesizing evidence from neuroimaging studies, post-mortem human cortical samples, and animal models, this review emphasizes the PFC as a vulnerable brain region where α-Syn-mediated synaptic dysfunction translates into cognitive and emotional deficits. Deciphering these early synaptic alterations is essential for developing neuroprotective strategies that preserve cortical function in PD and DLB. Full article

The pyrolysis of polypropylene (PP) microplastics offers a potential route to convert plastic waste into fuel-range hydrocarbon mixtures and chemical feedstocks. However, the elementary radical pathways underlying the formation of medium-chain hydrocarbon fragments remain insufficiently resolved. In this study, a representative isotactic PP oligomer model (C₄₅H₉₂) was evaluated using a comparative density functional theory (DFT) framework. The main mechanistic analysis was based on M06-2X, ωB97X-D, and M11 calculations combined with the def2-TZVP basis set, whereas LANL2DZ was retained only as a lower-cost comparative level during reaction-pathway exploration. Thermochemical profiles were evaluated over a temperature range of 298–923 K. Three selected pathways involving mid-chain homolytic cleavage, intramolecular hydrogen transfer (backbiting), radical rearrangement, and β-scission were examined. Within the selected reaction set, Route 1 exhibited a comparatively more favorable thermochemical profile than Routes 2 and 3 and provided a mechanistically plausible sequence toward medium-chain hydrocarbon fragments. The −TΔS contribution strongly influenced the calculated Gibbs free-energy profiles because fragmentation increases the number of molecular species under the ideal-gas thermochemical approximation. Accordingly, the ΔG values were interpreted comparatively and were not treated as direct evidence of spontaneous fragmentation under condensed-phase pyrolysis conditions or as quantitative predictions of experimental product selectivity. Differences among the evaluated functionals further indicate that the relative description of radical intermediates and transition-state regions is method-dependent. These results provide a molecular-level framework for future studies integrating quantum-chemical calculations, microkinetic modeling, and experimental product characterization. Full article

Annulated organic molecular structures with planar, fused backbones exhibit superior properties compared to non-fused systems, including high crystallinity, strong π–π stacking, and excellent charge transport characteristics. The rational design of annulated compounds with targeted characteristics presents a significant challenge that requires a comprehensive understanding of structure–property relationships. This work addresses this by synthesizing a series of novel push–pull systems featuring benzothieno[3,2-b]benzothiophene (BT) or its nitrogen-rich analogue, indolo[3,2-b]indole (ID), as electron-donating units, connected via a phenylene π-spacer to two distinct electron-accepting groups (carbonyl or dicyanovinyl). The thermal, structural, optical and electrochemical properties of these compounds were thoroughly investigated. Computational studies of the optical and electrochemical properties, including those of unsubstituted ID and BT model cores, showed excellent agreement with experimental data, validating the theoretical models. Notably, ID-based derivatives exhibited remarkably high photoluminescence quantum yield and enhanced solubility compared to their BT counterparts, along with thermal properties that are more favorable for device fabrication. This work provides the first systematic comparison of these annulated cores, offering novel structure–property insights that may support the rational design of organic functional materials and contribute to the further development of organic electronics. Full article

This study investigates anion–anion assemblies involving perhalate anions, XO₄⁻ (X = Cl, Br, I), in crystal structures retrieved from the Cambridge Structural Database to clarify the nature of the intermolecular interactions frequently interpreted as halogen bonds. Molecular electrostatic surface potential analysis demonstrates that isolated XO₄⁻ anions do not exhibit electrophilic σ-holes on the halogen or oxygen atoms along the O–X bond extensions, thereby precluding their role as conventional halogen- or chalcogen-bond donors. Gas-phase calculations further show that direct anion–anion assemblies are intrinsically repulsive and unstable in isolation. However, when dielectric screening is introduced through implicit solvation models, metastable dimeric and oligomeric arrangements consistent with crystallographic motifs become accessible. Complementary QTAIM, IGMH, NBO, and SAPT analyses show that the observed X···O and O···O contacts are weak, environment-assisted anti-electrostatic interactions arising from a combination of dielectric screening, polarization, dispersion, and donor–acceptor contributions. The results demonstrate that the structural organization of perhalate anions in crystalline environments is governed primarily by collective environmental and crystal-packing effects rather than intrinsic attractive interactions between isolated anions. Full article

Objectives: Alzheimer’s disease (AD) is associated with impaired adult hippocampal neurogenesis (AHN). This study aimed to establish an in vitro model of Aβ_1–42 oligomer-damaged neural stem cells (NSCs) and to employ the 5×FAD mouse model of AD in vivo, and to evaluate the therapeutic effects of brain-derived neurotrophic factor-loaded hyaluronic acid hydrogel (BDNF-HA gel) on AHN. Methods: In vitro, BDNF-HA gel was co-cultured with Aβ_1–42 oligomer-impaired NSC spheres and evaluate NSC proliferation, migration, and differentiation. In vivo, BDNF-HA gel was infused intracerebroventricularly into 5×FAD mice. Using BrdU labeling, immunofluorescence, anterograde transsynaptic viral tracing, and behavioral tests, we assessed the effects of BDNF-HA gel on adult neurogenesis, newborn neuron integration into memory circuits, and cognitive function. Results: In vitro, BDNF-HA gel attenuated Aβ_1–42-induced NSC apoptosis, restored proliferation and migration, promoted differentiation into neuroblasts, newborn neurons, and oligodendrocytes, and alleviated mitochondrial depolarization and loss of mitochondrial mass. In vivo, despite the absence of significant Aβ plaques reduction in 5×FAD mice, BDNF-HA gel markedly enhanced NSC proliferation and neurogenesis in the subventricular zone (SVZ) and subgranular zone (SGZ). Behavioral tests further revealed significant improvements in object recognition, spatial working memory, and spatial reference memory. Conclusions: BDNF-HA gel can effectively counteract the toxic microenvironment induced by Aβ oligomers, promoting NSC proliferation, migration, and differentiation into neurons. Without altering the Aβ burden, it significantly enhances adult neurogenesis and rescues cognitive deficits in AD mice. Full article

Background: Type 2 diabetes is projected to affect millions of people annually as the number of cases rises year on year. This includes children. Treating diabetes and its related comorbidities has a huge economic impact and puts pressure on healthcare providers. Understanding the disease at a molecular level is key for developing better therapeutics. The protein Islet Amyloid Polypeptide (IAPP) or amylin is important for glucose regulation; however, it is also instrumental in type 2 diabetes pathology. Human IAPP can misfold into oligomers and amyloid fibrillar aggregates within pancreatic islets, promoting β-cell dysfunction and death, contributing to progressive insulin deficiency and worsening hyperglycaemia. Methods: Based on previous studies on mutations at residues 18, 28 and 31,we have designed three novel IAPP analogues (two double and one triple mutant) to assess whether the combined amino acid substitutions impact fibril formation, solubility and toxicity. Results: All three of our analogues show a reduced propensity to aggregate and are more soluble than wild type IAPP. Compared with pramlintide, a clinically prescribed synthetic analogue of human amylin, all of our analogues appeared to have similarly reduced toxicity and improved solubility relative to human IAPP. Additionally, two of our analogues exhibited a markedly slower rate of fibril formation. Conclusions: Our results highlight the importance of targeting multiple residues as a promising strategy for developing improved diabetes therapeutics in the future. Full article

Background/Objectives: Antimicrobial peptides (AMPs) are promising candidates against multidrug-resistant bacteria, although their clinical translation is frequently limited by cytotoxicity. In this study, we investigated whether combinations of structurally related oligomeric analogs could cooperatively enhance bacterial membrane targeting while redistributing the associated cytotoxic burden. Methods: Monomeric, dimeric, and tetrameric AMPs were evaluated through antimicrobial susceptibility testing, checkerboard interaction assays, RAW 264.7 macrophage cytotoxicity assays, and all-atom molecular dynamics simulations, including biased membrane insertion and umbrella sampling analyses. In addition, we introduced the Combinatorial Therapeutic Index (CTI) as an exploratory metric to estimate the predicted reduction in cytotoxic burden associated with peptide combinations. Results: Cytotoxicity varied substantially among oligomeric forms, with larger and more hydrophobic peptides, particularly tetramers, exhibiting the highest cytotoxicity. Additive effects were observed in checkerboard assays involving linear, dimeric, and tetrameric forms, supporting the redistribution of the toxic burden and enabling the beneficial membrane-interaction properties of hydrophobic linear peptides to be leveraged at lower cytotoxic cost. Predicted therapeutic improvement ranged from approximately twofold for the SET-M33:L33 combination to nearly ninefold for the SET-M33:DIM-33:L8 triple combination. Molecular dynamics simulations revealed non-redundant membrane interaction behaviors, with smaller peptides exhibiting deeper membrane insertion and the dimeric form favoring interfacial membrane engagement. Conclusions: These findings support a cooperative formulation strategy in which structurally related SET-M33 oligomers contribute complementary antibacterial functions while reducing the predicted cytotoxic burden. Further experimental validation using direct cytotoxicity assays of complete peptide mixtures will be necessary to confirm the therapeutic potential of these formulations. Full article

The recycling of polyethylene terephthalate (PET) into value-added products suitable for additive manufacturing remains challenging due to molecular degradation and insufficient melt strength. In this study, post-consumer recycled PET was upcycled via chain extension to develop filaments suitable for fused filament fabrication (FFF). Two chain extenders were evaluated: an epoxy-based multifunctional oligomer (Joncryl^® ADR-4468) and a tetrafunctional aromatic dianhydride (pyromellitic dianhydride, PMDA). Joncryl^® ADR-4468 increased the complex viscosity and viscoelastic moduli of rPET; however, the response was non-monotonic and resulted in limited filament dimensional stability. In contrast, rPET/vPET (70/30) blends modified with PMDA exhibited a pronounced and reproducible enhancement in melt viscosity and elasticity, enabling the production of a continuous filament with a stable diameter (1.75 ± 0.05 mm). Differential scanning calorimetry indicated that PMDA had a negligible effect on the glass transition temperature, while slightly reducing crystallinity, which is beneficial for FFF processing. Preliminary printing trials confirmed stable extrusion and controlled deposition behaviour for the PMDA-modified formulation. Overall, the results demonstrate that chain extension using PMDA is an effective strategy to restore melt processability and enable the use of recycled PET in filament-based additive manufacturing. Full article

Phenol (Ph), bisphenol A (BPA), and cresol isomers (o-, m-, p-C) are pollutants widely detected in industrial effluents and resistant to conventional treatment. This study investigated the catalytic potential of manganese peroxidase (MnP), derived from Phanerochaete chrysosporium and expressed in corn, for the removal, via oxidative oligomerization and precipitation, of these compounds from water. Batch experiments were conducted under controlled pH, hydrogen peroxide concentration, and enzyme activity to achieve ≥95% substrate conversion. The optimized MnP system nearly achieved this under stepwise hydrogen peroxide addition. Kinetic analyses revealed short half-lives for initial degradation phases, with BPA and p-C showing near-instantaneous transformation. Mass spectrometry confirmed the formation of soluble and insoluble oligomers (to hexamers for BPA, octamers for p-C, dodecamers for the rest), confirming radical-mediated polymerization pathways. These findings highlight MnP as a robust and eco-friendly biocatalyst for efficient treatment of phenolic pollutants, offering significant potential for integration into advanced wastewater treatment systems. Full article

RNA-based therapeutics are reshaping the treatment landscape for skeletal muscle disorders by enabling modulation of RNA processing or direct correction of disease-causing alleles. In Duchenne muscular dystrophy (DMD), four antisense oligonucleotides—eteplirsen, golodirsen, viltolarsen, and casimersen—have received FDA approval; these phosphorodiamidate morpholino oligomers (PMOs) induce exon skipping to restore the reading frame and enable expression of internally truncated dystrophin. Beyond splice switching, RNA therapeutics include RNase H-active gapmers and steric-blocking antisense oligonucleotides (ASOs), small interfering RNAs (siRNAs) that mediate post-transcriptional gene silencing, and RNA-guided gene-modifying technologies such as CRISPR systems that can reframe or repair endogenous alleles. Despite major progress in DMD, broader clinical impact remains constrained by inefficient delivery to skeletal and especially cardiac muscle, the need for repeat administration for most modalities, and safety considerations that limit dose escalation and durability. Next-generation approaches aim to overcome these barriers through peptide- or antibody-conjugated oligonucleotides that enhance cellular uptake and tissue distribution, alternative chemistries with improved stability and potency, and viral or non-viral platforms for durable splice modulation. In parallel, CRISPR-based strategies—including base and prime editing—offer the prospect of one-time correction, while raising important questions regarding delivery, immunogenicity, editing specificity, and long-term safety. This review synthesizes recent advances in antisense and gene-modifying strategies for skeletal muscle and highlights practical priorities for translation, including improved muscle/heart delivery, controllable safety mechanisms, scalable manufacturing, and standardized biomarker-to-clinical outcome relationships. Full article

Background/Objectives: Protein–carbohydrate interactions are implicated in amyloid aggregation pathways associated with Alzheimer’s disease (AD). Designing glycomimetics that modulate amyloid assembly represents a promising strategy. In addition, the interaction of Aβ_1–42 oligomers (Aβo) with prion protein (PrP^C) activates Fyn kinase and leads to Tau hyperphosphorylation, another process characterizing AD. Thus, we generated a library of phenyl 2-acetamidoselenogalactoside mimetics to evaluate their interactions with Aβo and disruption of Aβo–PrP^C binding, and consequently their potential to inhibit Fyn kinase activation. Methods: The synthetic approach comprised azidophenylselenylation, a modified one-pot Staudinger reduction–acylation, a selective α-glycosylation, and deacetylation. Structural diversity was achieved mainly via acylation or ureation. The compounds were screened for binding to Aβo using STD-NMR, ¹⁹F-NMR, and rapid equilibrium dialysis (RED). ADME properties were assessed through microsomal metabolism and solubility assays, while cytotoxicity was evaluated by MTT assays in human embryonic kidney (HEK) cells. Results: Several compounds bound Aβo in STD-NMR experiments, mainly through aromatic and anomeric protons, and phenyl 2-deoxy-2-phenylureido-1-seleno-α-d-galactopyranoside (34) showed the most consistent response, with >50% increase in relative binding signal in competition assays, demonstrating also some inhibition of Aβo–PrP^C interactions (12%). Selenium at the anomeric position enhanced binding compared to sulphur and oxygen analogs. RED experiments confirmed weak binding interactions, consistent with STD-NMR results. ADME revealed that acetylated compounds undergo microsomal metabolism, whereas deacetylated derivatives displayed high aqueous solubility (>100 μM) and showed no cytotoxicity. Conclusions: Phenyl 2-acetamidoselenogalactosides are a novel class of amyloid-binding glycomimetics. Among them, 34 emerges as the most promising compound, combining favorable solubility, metabolic stability, low toxicity, and measurable interference with Aβo and Aβo–PrP^C interactions, thus supporting further developments toward therapeutic applications in AD. Full article

Fibroblast Growth Factor 2 (FGF2) is a highly effective regulator of cell proliferation, differentiation, migration, and adhesion, suggesting a significant therapeutic potential as a tissue regeneration promoter both in acute and chronic tissue damage settings. Despite an extensive list of pathologies that lend themselves as viable targets for FGF2-based therapy (ranging from periodontics to burns to diabetic ulcers to coronary artery disease), the success record in the clinic remains modest, with no FDA approvals obtained so far. The inferior stability of this protein is frequently cited as the most significant factor behind its disappointing performance as a biotherapeutic. Multiple strategies have been designed and tested in an effort to ameliorate this problem, but the success remains elusive. We investigate the aggregation propensity of a recombinantly produced FGF2 using native mass spectrometry (MS) to identify conditions favoring formation of small soluble oligomers, which are considered precursors to larger aggregates. Tandem MS of proteolytic fragments produced by digestion of the oligomeric species allows the formation of external disulfide bonds to be identified as the process leading to oligomerization. Specifically, Cys-31 (one of the two unpaired cysteine residues in intact FGF2) appears to be a particularly active promoter of oligomerization by forming external disulfide bonds. As a high-pI protein, FGF2 readily associates with heparin, and molecular modeling identifies a positive charge basin proximal to Cys-31 as a potential heparin binding site, which can readily accommodate a synthetic heparin mimetic fondaparinux. Adding an equimolar amount of the latter to the FGF2 solution not only leads to formation of a stable protein/polyanion complex (as revealed by native MS), but also inhibits formation of FGF2 oligomers (presumably via a combination of steric hindrance and electrostatic repulsion). These findings advance our understanding of FGF2 stability, which will be invaluable for optimizing its formulation, storage, and administration. Full article

Amyloid-β (Aβ) aggregation is a central mechanistic feature of Alzheimer’s disease, involving heterogeneous conformational ensembles that evolve through monomeric, oligomeric, and fibrillar states. Understanding how small molecules modulate these state-dependent processes remains a major challenge in medicinal chemistry. This review examines the molecular mechanisms by which (-)-epigallocatechin-3-gallate (EGCG) perturbs Aβ aggregation, with a focus on insights derived from molecular dynamics (MD) simulations integrated with experimental data. MD studies employing structural, dynamical, and interaction-based descriptors (e.g., β-sheet content, contact maps, and salt bridge persistence) reveal that EGCG acts as a state-dependent modulator: it redistributes monomeric ensembles by masking aggregation-prone regions, induces topology switching in oligomers that suppresses seeding competence, and destabilizes protofibrillar β-sheet networks through interfacial and node-targeting interactions. Methodological analysis highlights the importance of force field selection, sampling depth, and aggregate model dependence, leading to a hierarchy of mechanistic confidence that distinguishes well-supported trends from model-specific observations. From a medicinal chemistry perspective, EGCG is best interpreted as a mechanistic probe rather than as a lead compound, informing the design of biostable modulators through principles such as bioisosteric replacement, topology control, and interfacial targeting. Collectively, this work provides a framework for translating the state-dependent aggregation mechanisms into rational therapeutic strategies. Full article

Tissue engineering represents a central strategy in regenerative medicine to restore damaged or missing tissue through structural and functional replacement. In this study, a two-component bioink platform was developed based on amine–anhydride conjugation as a mild crosslinking reaction between synthetic anhydride-containing oligomers (oSMoMA-x) and natural biopolymers. The compatibility of the oligomers with different amine-containing biopolymers, including chitosan, gelatin, and hydrolyzed collagen peptides, was systematically evaluated. To improve cytocompatibility and enable controlled network formation, oSMoMA oligomers with varying anhydride contents were synthesized and characterized, allowing targeted tuning of material properties through comonomer composition. The resulting hydrogels were comparatively assessed with respect to their rheological and physicochemical properties. While hydrogel formation was achieved with all investigated biopolymers, gelatin-based systems exhibited the most favorable characteristics for bioink development. Two gelatin/oSMoMA bioink formulations with distinct gelation behavior were obtained by employing different base catalysts, enabling control over crosslinking kinetics and material properties. Cytocompatibility was comprehensively evaluated using viability assays, demonstrating enhanced metabolic activity of cells encapsulated in gelatin/oSMoMA-3.5 hydrogels compared to established reference systems, with sustained compatibility for up to seven days. Extrusion-based 3D bioprinting was performed using a modified printhead with integrated temperature control to maintain physiological conditions. The bioinks were successfully printed with embedded murine 3T3 fibroblasts, and post-printing analyses confirmed cell proliferation within the hydrogel constructs. Overall, the results demonstrate the broad compatibility of amin–anhydride-crosslinked oSMoMA systems with different biopolymers and highlight gelatin/oSMoMA bioinks as promising cytocompatible materials for stable 3D bioprinting applications in tissue engineering. Full article

In this study, fully bio-based oligomers of butylene succinate (OBS) with different molecular weights (low: L-OBS, medium: M-OBS and high: H-OBS) were incorporated into poly(butylene succinate) (PBS) by melt mixing at varying loadings of 5–15 wt%. Then, PBS/OBS films were obtained by thermo-compression and characterized to assess their suitability for sustainable food packaging. Thus, OBS were homogeneously incorporated into PBS matrix and modulated the thermal, mechanical, and barrier properties of the PBS. L-OBS (Mn = 1150 g·mol⁻¹) plasticized the amorphous PBS, depending on its concentration, more effectively than M-OBS (Mn: 8700 g·mol⁻¹) and H-OBS (Mn: 18,650 g·mol⁻¹), as deduced from the thermo-mechanical analysis. In every case, OBS enhanced crystallinity, mainly L-OBS, which reduced the film strength and increased water vapor permeability, depending on its concentration. In contrast, H-OBS improved mechanical strength, stiffness, and barrier performance. In all cases, X-ray diffraction confirmed the preservation of the PBS’s monoclinic crystalline structure but slightly shifted the diffraction angle depending on the ratio of the end-chain groups in the blend, thus reflecting the contribution of OBS in the crystalline lattice. Finally, oligomer incorporation resulted in an overall migration increase in different food simulants, impairing their application in packaging. Full article